Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Observational
Observational Model: Case-Crossover, Time Perspective: Prospective
Number of participants with increased intraprostatic lipid concentration
Determine the correlation between the amount of intraprostatic lipid using 1H magnetic resonance spectroscopic imaging (MRSI) with an endorectal coil obtained prior to prostatectomy with fatty acid synthase protein expression measured in benign and cancer tissue from prostatectomy samples.
Up to 3 years
No
Jackilen Shannon, PhD
Principal Investigator
Oregon Health and Science University
United States: Institutional Review Board
PC110361/ PC110361P1
NCT01780701
January 2013
March 2015
Name | Location |
---|---|
Portland VA Medical Center | Portland, Oregon 97239 |
Oregon Health & Science University Advanced Imaging Research Center | Portland, Oregon 97239 |